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Time MRI
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Background: Quantitative MRI of patellar tendinopathy (PT) can be challenging due to spatial variation of T2* relaxation times.
Purpose: 1) To compare T2* quantiﬁcation using a standard approach with analysis in speciﬁc tissue compartments of the patellar
tendon. 2) To evaluate test–retest reliability of different methods for ﬁtting ultrashort echo time (UTE)-relaxometry data.
Study Type: Prospective.
Subjects: Sixty-ﬁve athletes with PT.
Field Strength/Sequence: 3D UTE scans covering the patellar tendon were acquired using a 3.0T scanner and a
16-channel surface coil.
Assessment: Voxelwise median T2* was quantiﬁed with monoexponential, fractional-order, and biexponential ﬁtting. We
applied two methods for T2* analysis: ﬁrst, a standard approach by analyzing all voxels covering the proximal patellar ten-
don. Second, within subregions of the patellar tendon, by using thresholds on biexponential ﬁtting parameter percentage
short T2* (0–30% for mostly long T2*, 30–60% for mixed T2*, and 60–100% for mostly short T2*).
Statistical Tests: Average test–retest reliability was assessed in three athletes using coefﬁcients-of-variation (CV) and
coefﬁcients-of-repeatability (CR).
Results: With standard image analysis, we found a median [interquartile range, IQR] monoexponential T2* of 6.43 msec
[4.32–8.55] and fractional order T2* 4.39 msec [3.06–5.78]. The percentage of short T2* components was 52.9%
[35.5–69.6]. Subregional monoexponential T2* was 13.78 msec [12.11–16.46], 7.65 msec [6.49–8.61], and 3.05 msec
[2.52–3.60] and fractional order T2* 11.82 msec [10.09–14.44], 5.14 msec [4.25–5.96], and 2.19 msec [1.82–2.64] for
0–30%, 30–60%, and 60–100% short T2*, respectively. Biexponential component short T2* was 1.693 msec [1.417–2.003]
for tissue with mostly short T2* and long T2* of 15.79 msec [13.47–18.61] for mostly long T2*. The average CR (CV) was
2 msec (15%), 2 msec (19%) and 10% (22%) for monoexponential, fractional order and percentage short T2*, respectively.
Data Conclusion: Patellar tendinopathy is characterized by regional variability in binding states of water. Quantitative
multicompartment T2* analysis in PT can be facilitated using a voxel selection method based on using biexponential ﬁtting
parameters.
Level of Evidence: 1
Technical Efﬁcacy Stage: 1
J. MAGN. RESON. IMAGING 2020.
Patellar tendinopathy (PT) is an overuse tendon injurythat is typically observed in athletes performing repeti-
tive jumping activities, such as volleyball and basketball.1
PT results in load-related anterior knee pain at the site of
the patellar tendon attachment to the patella.2 Pain in PT
is often chronic, resulting in decreased activity levels and in
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more than half of the patients in decreased work
participation.3,4
On histopathological analysis, PT is associated with
degenerative tissue changes that are typically located at the
posterior aspect of the proximal patellar tendon.5 Histopatho-
logical features of tendinopathy include collagen disorganiza-
tion and ﬁber separation with increased proteoglycans and
associated glycosaminoglycan (GAG) side chains within the
extracellular matrix.6 This accumulation of GAGs in the
proximal patellar tendon leads to an increased water content
within the extracellular matrix, because of the highly negative
charge of GAGs with a strong potential for binding water.7 A
simpliﬁed model to characterize the different water pools
within the patellar tendon is the bicomponent model.8 Water
in voxels that contain highly organized collagen is primarily
in a “bound” state, thereby restricting the motion of water
molecules by stronger spin–spin interactions, thus resulting in
shorter T2* relaxation times (reﬂecting the macromolecular
bound water compartment). Loosely bound water or even
“free” water pools result in a longer T2*.
9 The different water
pools reﬂect speciﬁc tissue compartments within the patellar
tendon.10 Quantifying these different water pools may be
clinically relevant, as a previous histological study in patients
undergoing surgery demonstrated an association between
levels of GAGs and severity of PT symptoms.11
Currently, imaging in PT with morphologic magnetic
resonance imaging (MRI) techniques is of limited value,
because the diagnosis of PT is primarily made clinically.12
These MR techniques are sensitive for detecting increased sig-
nal in the proximal patellar tendon, representing an elevated
water content.13 However, conventional MRI of tendons is
typically limited for the assessment of different water pools in
the patellar tendon due to the fast free induction decay of col-
lagen.12 The short T2*-components in tendons will conse-
quently appear dark using conventional sequences. Ultrashort
echo time (UTE) sequences are sensitive to different water
pools in the patellar tendon.14 Quantitative T2* mapping is
performed by multiple-spin-echo decay analysis using
voxelwise ﬁtting methods.15 Monoexponential, or single-
component ﬁtting is a robust method to describe signal decay
in which the MR signal in each voxel is assumed to result
from only a single component. However, residual signal is
observed using this method, indicating that the signal from
each voxel consists of different components.9 In order to gain
insight in this subpixel composition, the biexponential model
has been introduced to reveal both short and long water com-
ponents in each voxel.16 Fractional order ﬁtting has also been
proposed as an alternative mathematical model to describe
relaxation in complex heterogeneous tissues and is derived
from a nonlinear generalization of the Bloch equations.17
The primary aim of this study, therefore, was to quantify
T2* in speciﬁc tissue compartments by optimizing the image
analysis approach in which voxels containing comparable water
pools are automatically selected. Moreover, we compared dif-
ferent methods for ﬁtting T2* relaxometry data and evaluated
test–retest reliability of the T2* quantiﬁcation.
Materials and Methods
This single-center prospective observational study was approved by the
local Institutional Review Board (decision number: NL58512.078.16).
Participants provided written informed consent prior to inclusion. We
performed cross-sectional analysis of baseline data from a prospective
trial investigating the effectiveness of two different exercise programs
for PT.
Study Population
Participants were consecutively recruited. To be eligible for inclu-
sion, athletes aged 18–35 years must have a clinical diagnosis of
patellar tendinopathy that was conﬁrmed by ultrasound and had to
perform sports involving frequent jumping or cutting maneuvers for
at least 3 times per week. The activity level was assessed using the
Cincinnati Sports Activity Scale (CSAS), which incorporates both
frequency of sports participation and the general types of forces
experienced by the lower extremity during the sport.18 The Victo-
rian Institute of Sports Assessment questionnaire for patellar tendons
(VISA-P) was administered to measure symptoms, function, and
ability to play sports.19 Criteria for the clinical diagnosis were: 1) a
history of localized pain at the inferior pole of the patella, 2) recog-
nizable pain on palpation over the patellar tendon, and 3) injury
pain on the single leg squat. Clinical evaluation was performed by a
sports physician (R.V.) with 10 years of experience in athlete care.
The clinical evaluation was followed by an ultrasound examination
(LOGIQ E9, GE Healthcare, Chicago, IL) of the patellar tendon
performed by one trained examiner (S.B.: radiologist-in-training
with 5 years’ experience), and was regarded positive for PT when
there was the presence of structural and/or hypoechoic changes
and/or tendon thickening (anterior–posterior diameter >6 mm)
and/or the presence of intratendinous power Doppler ﬂow.20 Other
eligibility criteria are mentioned in the preregistered trial protocol,
ClinicalTrials.gov (ID: NCT02938143).
MR Examination
MRI was performed with a 3.0T clinical scanner (Discovery
MR750, GE Healthcare, Waukesha, WI) using a 16-channel small
ﬂexible coil (NeoCoil, Pewaukee, WI). For stabilization of the knee,
a support device was used in combination with a plastic cylindrical
tube and foam padding to keep the knee ﬂexed at 30 (Fig. 1). The
center-spot of the coil was aligned with the inferior patellar border.
Acquisition was initiated with a sagittal 3D proton-density (PD) fast
spin echo sequence of the knee, which was subsequently used to cre-
ate precise localizer images to plan further acquisitions aligned with
the direction of the collagen ﬁbers of the patellar tendon. The patel-
lar tendon was scanned in the axial plane using 3D-UTE-Cones
(GE Healthcare), which is a gradient-echo-based acquisition using
radial readout of the k-space. A total of 16 echoes were acquired in
four separate multiecho sequences containing four echoes in inter-
leaved order. For each multiecho acquisition, the same repetition
time (TR) was used. Total acquisition time was 65 minutes. The full
protocol for sequence parameters in this study is listed in Table 1.
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The MR examination was repeated in three athletes with patellar
tendinopathy, who returned the next day for the purpose of measur-
ing reproducibility.
Image Preparation
Image registration was performed in order to perform a spatial one-
to-one mapping from voxels between the different UTE acquisitions
with in-house-developed registration tools (Elastix v. 4.8, Rotterdam,
The Netherlands)21,22 and MatLab software (R2015b; MathWorks,
Natick, MA). Initially, a rigid registration to correct for rotation and
translation was performed on the entire knee to compensate for
motion in between multiecho scans and separate visits (for the test–
retest subjects). Second, a groupwise nonlinear reﬁnement registra-
tion was performed inside a volume of interest covering the patellar
tendon.22 The volume of interest was constructed from regions of
interest drawn on three orthogonal views.
FIGURE 1: Standardized positioning of the knee during MRI. Illustrated is the positioning of the 16-channel ﬂexible coil in
combination with the support device that was used for knee stabilization and standardization of the knee ﬂexion angle.
TABLE 1. Imaging Protocol
Sequence 3D PD Cube 3D PD Cube FS 3D ME-UTE
Matrix 384 × 384 384 × 384 252 × 252
Scan plane Sagittal Sagittal Axial oblique
Fat saturation — Fat 2 excitations per FS
FOV (cm) 15.0 15.0 15.0
Resolution (mm) 0.4 × 0.4 × 1.0 0.4 × 0.4 × 1.0 0.6 × 0.6 × 1.5
Slice thickness (mm) 1.0 1.0 1.5
Number of slices 120 120 60
TE (msec) 30.0 30.0 0.032/4.87/12.67/20.47
0.49/6.82/14.62/22.42
0.97/8.77/16.57/24.37
2.92/10.72/18.52/26.32
Number of echoes 1 1 16
TR (msec) 1200.0 1200.0 83.4
Flip angle () 17
Bandwidth ( kHz) 83.33 83.33 125
NEX 0.5 0.5 1.0
Scan time (mm:ss) 03:17 03:18 13:15
PD: proton density; ME: multiecho; UTE: ultrashort echo time; FOV: ﬁeld-of-view; FS: fat saturation; TE: echo time; TR: repetition
time; NEX: number of excitations.
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Fitting Methods
Fitting of the UTE-T2* maps was performed using different models,
namely, monoexponential, fractional order, and biexponential ﬁtting.
The T2* relaxation time was calculated using three different analysis
algorithms, written in MatLab (R2015b; MathWorks).
Monoexponential T2* was ﬁtted using the model
23:
Mm TEð Þ = a0  e
−TE
T *
2 ð1Þ
where a0 is the signal intensity at echo time (TE) = 0.
For biexponential T2* analysis, short T2* (T2S*) and long
T2* (T2L*) components were ﬁtted with the model
23:
Mb TEð Þ = b0  e
− TE
T *
2S + b1  e
− TE
T *
2L ð2Þ
where b0 and b1 are the magnetization of the short T2* and long
T2* components, respectively.
The fractional order T2* relaxation model is given by
17:
Mf TEð Þ = c0 Eα − TET 2
 α 
ð3Þ
where c0 is the signal intensity at TE = 0 and Eα is the stretched
Mittag–Lefﬂer (M-L) function.24 Note that for α = 1, the M-L func-
tion is equivalent to the monoexponential function.
Fractional order ﬁtting results in a stretched exponential T2*
and a parameter “α” (0 < α < 1) of the differential equation, which
represents tissue heterogeneity.25 In a voxel where α = 1, the signal
decay is best described as monoexponential and likely resulted from
a single component. We used maximum likelihood estimation incor-
porating the Rician noise model for ﬁtting the parameters of all
methods.26 This corrects for the noise-dependent bias in magnitude
images.27
Image Analysis
For calculation of median T2* relaxation times for the mono-
exponential, fractional order and biexponential ﬁtting parameters
in all subjects, we selected individual voxel data on 10 consecutive
slices covering the proximal patellar tendon and for each separate
slice of the proximal patellar tendon (Fig. 2). On each slice, we
drew a mask that covered the outer margins of the patellar tendon,
in order to analyze all voxels. The ﬁrst region of interest (ROI)
was drawn on the second slice distal from the patellar apex, to
avoid partial volume effects of patellar bone. The subregional anal-
ysis in different tissue compartments was performed using thresh-
olds on the percentage short T2* components, a parameter
resulting from biexponential ﬁtting. The thresholds resulted in an
automatic selection of voxels within the mask of the patellar ten-
don, indicating the different tissue compartments. Based on the
frequency distribution of the percentage short T2* components in
a histogram, we deﬁned 0–30% short T2* components for the
highly hydrated degenerative tissue, which mainly contains long
T2* components, 30–60% short T2* as the intermediate zone,
and 60–100% for the ultrashort T2* components, such as the
macromolecular bound water pools associated with aligned colla-
gen. For quantitative analysis, only voxels within the initial mask
covering the patellar tendon were selected.
Statistical Analysis
Statistical analysis was performed using IBM SPSS software
v. 25 (Armonk, NY). Coefﬁcients-of-variation (CV) were calculated
using the root-mean-square method to assess test–retest reliability in
each voxel. In this method, the CV is calculated voxelwise as the square
root of the squared summed percentage differences in each voxel
between the test and retest scans divided by the total number of voxels.28
Within-subject variances were calculated as half the square of the differ-
ences between two scans.29 Test–retest repeatability was assessed using
coefﬁcient-of-repeatability (CR), also referred to as smallest real
FIGURE 2: Locations for T2* quantiﬁcation in patellar tendinopathy. (a) Sagittal PD Cube scan in an athlete with patellar
tendinopathy and corresponding sagittal (b) and coronal (c) 3D-UTE scans (TE 4.87 msec). Color bars in the proximal patellar tendon
represent the locations of the manually drawn masks in 10 slices for T2* quantiﬁcation.
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difference (SRD), calculated by multiplying the median within-subject
standard deviation by 2.77 (√2 times 1.96).30 Overall CV and CR were
calculated as a mean over the three subjects. Normality of data was tested
using the Shapiro–Wilk’s test. One-way analysis of variance (ANOVA)
was used to determine whether there were statistically signiﬁcant differ-
ences between the means of the subselected voxel groups. Differences
between monoexponential ﬁtting and fractional order ﬁtting were
assessed with Student’s t-test for normally distributed data and the
Mann–Whitney U-test for nonnormally distributed data. Statistical sig-
niﬁcance was deﬁned as P < 0.05.
Results
Study Population
In total, 76 athletes with clinically diagnosed and ultrasono-
graphically conﬁrmed PT were consecutively enrolled between
January 2017 and June 2019. After exclusion of 11 subjects due to
a change in our MR acquisition protocol during the study period,
65 athletes remained eligible for inclusion. Demographic character-
istics of the study population are listed in Table 2.
Acquired 3D UTE-Cones Images
Figure 3a shows axial images of the knee in an athlete with
patellar tendinopathy at all 16 echoes of the 3D UTE-Cones
acquisitions, illustrating the fast signal decay occurring at the
shortest echo times. Figure 3b–d shows signal intensity curves in
the different tissue compartments of the patellar tendon (mostly
long T2*, mixed T2*, and mostly short T2*), ﬁtted using mon-
oexponential, biexponential, and fractional order models.
Image Analysis Using All Voxels
When using all voxels in all slices covering the proximal patellar ten-
don, we found a median [interquartile range, IQR] mono-
exponential T2* of 6.43 msec [4.32–8.55] and fractional order T2*
4.39msec [3.06–5.78]. The overall percentage of short T2* compo-
nents was 52.9% [35.5–69.6]. Table 3 illustrates that the longest
T2* was found in the slice closest to the inferior patellar border (slice
1) and gradually decreased in the distal direction. Fractional order
T2* revealed a similar gradual decrease; however, fractional order
T2* was systematically lower than monoexponential T2*. In addi-
tion, the percentage of short T2* components was lowest in the slice
closest to the inferior patellar border and gradually increased in the
distal direction along the patellar tendon. The difference in median
T2* between the monoexponential and fractional order ﬁtting in all
voxels was statistically signiﬁcant (P < 0.001).
Subregional Image Analysis Approach
In Fig. 4, a representative axial slice of an athlete with patellar
tendinopathy is illustrated with the corresponding mono-
exponential, biexponential, and fractional-order T2* maps.
Voxels were selected with a percentage of short T2* between
0–30%, 30–60%, and 60–100% based on histogram analysis
(Fig. 5), and visually corresponded to degenerative tissue,
transitional area between degenerative tissue and aligned
collagen, and aligned collagen in the patellar tendon, respec-
tively. There were statistically signiﬁcant differences in mono-
exponential and fractional order T2* between all three
different tissue compartments (P < 0.001). Table 4 illustrates
that the longest T2* was found in degenerative tissue (median
monoexponential T2* 13.78 msec, IQR [12.11–16.46], and
fractional order T2* 11.82 msec, IQR [10.09–14.44]) and
the shortest T2* in the voxels representing aligned collagen
(median monoexponential T2* 3.05 msec, IQR [2.52–3.60],
and fractional order T2* 2.19 msec [1.82–2.64]).
Test–Retest Reliability
Intravoxel test–retest CV and CR are listed in Table 5. Com-
parable reliability was found for monoexponential and frac-
tional order ﬁtting; we found an average CV of 15% and CR
of 2 msec and an average CV of 19% and CR of 2 msec,
respectively. The percentage short T2* (biexponential ﬁtting)
had an average CV of 22% and CR of 10%. Average repeat-
ability (CV) of biexponential T2* quantiﬁcation improved by
using the subregional image analysis approach from 45% to
30% for short T2* and from 25% to 11% for long T2* in
the subselected voxels with 60–100% short T2* components
TABLE 2. Baseline Characteristics
Characteristic N = 65
Mean age (years)  SD 24.5  3.8
No. of men (%) 50 (77)
Mean BMI (kg/m2)  SD 24.0  2.9
Mean waist circumference (cm)  SD 85.7  9.4
Mean clinical score
(VISA-P, 0–100)  SD
55  13
Median symptom duration (weeks)
[IQR]
104 [40–182]
Sports activity scale (CSAS, 0–100) N (%)
Level I (4 to 7 days/week)
100 15 (23)
95 0 (0)
90 0 (0)
Level II (1 to 3 days/week)
85 44 (68)
80 6 (9)
SD: standard deviation; IQR: interquartile range; BMI: body
mass index; VISA-P: Victorian Institute of Sports Assessment
questionnaire for patellar tendons; CSAS: Cincinnati Sports
Activity Scale.
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FIGURE 3: Axial 3D UTE-Cones images of the knee and corresponding T2* relaxation curves. (a) Axial images of the knee in a
21-year-old male basketball player with patellar tendinopathy at all 16 echoes acquired using the 3D UTE-Cones acquisitions. Note
that the signal in the voxels corresponding to aligned collagen in the patellar tendon rapidly decays, and is not visible anymore on
images with TEs of 4.87 msec and longer. (b) Signal intensity curves for an ROI in voxels containing mostly short T2* components
(aligned collagen). Note that there is signiﬁcant residual signal that is not ﬁtted by the monoexponential model and that there is
visibly improved curve ﬁt of the signal data when using the biexponential or fractional order model. (c) Signal intensity curves for an
ROI in voxels containing intermediate T2* components (interface between aligned collagen and degenerative tissue). (d) Signal
intensity curves for an ROI in voxels containing mostly long T2* components (degenerative tissue).
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and in the subselected voxels with 0–30% short T2* compo-
nents, respectively.
Discussion
We found that parameters resulting from biexponential ﬁtting
of UTE relaxometry data successfully led to the identiﬁcation
and quantiﬁcation of speciﬁc tissue compartments within the
patellar tendon in athletes with patellar tendinopathy and that
repeatability of biexponential T2* quantiﬁcation improved
using this subregional analysis compared to the standard
image analysis approach. The observed T2* distribution in
patellar tendinopathy was not homogeneous, but revealed
regional variations in binding states of water, in which aligned
collagen was characterized by ultrashort T2* and degenerative
tissue generally by long T2* components. Conventional
analysis with an ROI delineating the outer margins of the
patellar tendon averages the spatial differences in T2* relaxa-
tion time in these different compartments. Accordingly, in
such analyses the regional T2* variability complicates the
detection of changes over time.
Spatial Variability in T2* Relaxation
To overcome the issues of spatial T2* variation in the patellar
tendon, we introduced an alternative approach to quantify
T2* in speciﬁc tissue compartments. This is important for
identifying UTE-based biomarkers that better reﬂect tendon
structure, other than just analyzing the average over all voxels
containing different components resulting from different
binding states of water. Moreover, not only spatial variability
in T2* relaxation in the patellar tendon, but also the different
components in each voxel can be quantiﬁed using
biexponential ﬁtting of UTE relaxometry data. We hypothe-
sized that these speciﬁc biomarkers have more potential to
correlate with clinical ﬁndings and hopefully better reﬂect the
pathological changes observed in tendinopathy. Conceivably,
these speciﬁc biomarkers are surrogate markers for the
increased levels of glycosaminoglycans (GAGs) in patellar ten-
dinopathy, which have already been associated with worse
clinical status.11
FIGURE 4: Representative axial MR images in an athlete with
patellar tendinopathy. (a) Mask (blue) covering all voxels within
the outer margins of the patellar tendon. (b) Subselected voxels
with 60–100% short T2* components, corresponding to aligned
collagen in the patellar tendon. (c) Subselected voxels with
30–60% short T2* components, corresponding to the interface
between aligned collagen and degenerative tissue. (d)
Subselected voxels with 0–30% short components,
corresponding to degenerative tissue. (e) Original UTE image
(TE 4.82 msec) revealing the regional variations of T2* in patellar
tendinopathy, with hypointense aligned collagen and
hyperintense degenerative tissue. (f) Quantitative T2* map from
fractional order ﬁtting, depicting short T2* in dark blue
(0.032–10 msec) and longer T2* on a scale from light blue/green
(10–30 msec) to orange/red (30–60 msec). (g) Quantitative T2*
map from monoexponential ﬁtting, on the same scale as (f). (h)
Quantitative T2* map from biexponential ﬁtting, depicting the
percentage of short T2* components on a scale from dark blue
(0% short T2* components) to red (100% short T2* components).
FIGURE 5: Frequency distribution of the percentage of short T2*
components. Exemplary histogram of the frequency distribution
of the percentage of short T2* components in the proximal
patellar tendon. The different lines correspond to the manually
drawn masks in 10 slices (“prox1-prox10”) for T2* quantiﬁcation.
Note that there are two main peaks in the histogram, namely,
the component with mostly long T2* (left peak) and the
component with mostly short T2* (right peak). Based on this
frequency distribution, we opted to set thresholds at 30% and
60% short T2* components to distinguish between three
different water pools; “mostly short T2* (60-100% short T2*),”
“intermediate T2* (30-60% short T2*),” and “mostly long T2*
(0-30% short T2*).” Based on these thresholds on the
percentage short T2* components, the corresponding voxels
were automatically selected within each mask for analysis.
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Previous Studies
Previous studies have shown potential of bicomponent analy-
sis to discriminate between athletes with patellar ten-
dinopathy and healthy controls31 and to quantify different
water pools in heterogeneous tissues.9,32 Also, regional T2*
variations have been observed for the Achilles tendon32 and
segmentation of the entire patellar tendon volume was per-
formed to calculate mean T2*.
33 Those studies performing
T2* quantiﬁcation implemented sagittal scan planes and rela-
tively large ROIs, probably due to time restrictions.31,34 We
acquired UTE relaxation data in an axial oblique scan plane
with a high in-plane resolution, thereby facilitating the intro-
duced subregional quantiﬁcation.
Strengths
The strengths of our study are the relatively large sample size
and the homogeneity of the study population with respect to
age and level of sports. We applied strict eligibility criteria by
including only athletes with clinically and ultrasound-
conﬁrmed PT, and thereby ruling out other causes for
anterior knee pain. Another strength is that the UTE MRI
relaxation data were acquired by a single examiner using a
standardized protocol, regarding both patient positioning and
acquisition. Moreover, the postprocessing and analysis of the
data were performed by the same investigator.
Limitations
First, the biexponential model that we used for deﬁning the
thresholds for selection of voxels with comparable water pools
might be a simpliﬁed method. In fact, the MR signal in each
voxel can consist of more than two (short and long) compo-
nents.8 However, we found that the percentage of short T2*
components was able to clearly discriminate between the dif-
ferent tissue compartments in the patellar tendon. Moreover,
biexponential ﬁtting has been stated to be better than mono-
exponential ﬁtting, because of the systematic residual signal
that is seen with monoexponential ﬁtting.9 Second, the reli-
ability of the biexponential model is relatively poor compared
to the more robust monoexponential and fractional order
model in the small number of subjects included for reliability
measurements. However, the reliability of biexponential
ﬁtting parameters increased in speciﬁc tissue compartments
compared to the conventional image analysis approach.
Third, despite the noninvasiveness of MRI, the time-
consuming acquisition protocol and postprocessing pipeline
used in this study would both not be applicable in daily clini-
cal practice. However, the total acquisition time of our com-
prehensive 3D UTE-Cones T2* mapping protocol can be
shortened considerably by reducing the number of echoes
and number of slices acquired, without compromising the
T2* mapping results.
Further Implications
Further research projects could strengthen the need for T2*-
quantiﬁcation in speciﬁc tissue compartments in patellar
tendinopathy if longitudinal data depicted changes in T2*
relaxation over time. Subsequently, the effectiveness of differ-
ent therapeutic interventions for patellar tendinopathy could
be evaluated. Ultimately, imaging biomarkers would serve as
surrogate markers for the increase in GAGs, thereby strongly
facilitating the assessment of the severity of patellar ten-
dinopathy at a microstructural level. Accordingly, the thera-
peutic response could be quantiﬁed without the need of
histological samples.
Conclusion
Our study showed that quantitative multicompartment T2*
analysis in heterogeneous tissues such as the patellar tendon
can be facilitated using a voxel selection method based on
biexponential ﬁtting parameters that differentiate between tis-
sue compartments with comparable water pools, and that
monoexponential and fractional order ﬁtting methods have
equal reliability to quantify UTE relaxometry data. Subre-
gional quantitative analysis using 3D UTE MRI leads to the
identiﬁcation of tissue-speciﬁc T2* biomarkers with high
repeatability, which can facilitate the detection of changes in
the tendon hydration state over time, for example, as a result
of therapeutic interventions.
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